Literature DB >> 8146508

The effect of reimbursement on the use of antibiotics.

H Friis1, F Bro, N R Eriksen, C E Mabeck, R Vejlsgaard.   

Abstract

OBJECTIVE: To examine the effect of a reduction on the reimbursement of drugs on the use of antibiotics by general practitioners in Denmark.
DESIGN: A prospective study using a questionnaire comparing the results with a similar study 3 years before, a period with normal reimbursement. PARTICIPANTS: 553 general practitioners prescribed antibiotics for 5765 patients. MAIN OUTCOME MEASURE: Number of treated patients and choice of antibiotics.
RESULTS: 7607 patients were treated in 1987 compared with 5765 in 1990, the relative number of patients treated for sinusitis, other upper respiratory tract infections, acute bronchitis, pneumonia and upper gynaecological infections was significantly less in 1990 than in 1987. Other infections, particularly those that are often diagnosed by culture or microscopy by the general practitioners themselves, increased significantly. They included tonsillitis and urinary tract infections.
CONCLUSION: Reimbursement can be a very powerful tool controlling the use of antibiotics by general practitioners.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8146508     DOI: 10.3109/02813439308994839

Source DB:  PubMed          Journal:  Scand J Prim Health Care        ISSN: 0281-3432            Impact factor:   2.581


  4 in total

1.  Quality assessment of drug sales data: the case of antibacterials in Iceland.

Authors:  I Björnsdóttir; E H Hansen; A Grímsson
Journal:  Pharm World Sci       Date:  1999-10

Review 2.  Interventions to improve antibiotic prescribing practices in ambulatory care.

Authors:  S R Arnold; S E Straus
Journal:  Cochrane Database Syst Rev       Date:  2005-10-19

Review 3.  Outpatient antibiotic use and prevalence of antibiotic-resistant pneumococci in France and Germany: a sociocultural perspective.

Authors:  Stephan Harbarth; Werner Albrich; Christian Brun-Buisson
Journal:  Emerg Infect Dis       Date:  2002-12       Impact factor: 6.883

4.  What impact do prescription drug charges have on efficiency and equity? Evidence from high-income countries.

Authors:  Marin C Gemmill; Sarah Thomson; Elias Mossialos
Journal:  Int J Equity Health       Date:  2008-05-02
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.